642 related articles for article (PubMed ID: 29032724)
21. Effect of all-trans retinoic acid on sodium/iodide symporter expression, radioiodine uptake and gene expression profiles in a human anaplastic thyroid carcinoma cell line.
Jeong H; Kim YR; Kim KN; Choe JG; Chung JK; Kim MK
Nucl Med Biol; 2006 Oct; 33(7):875-82. PubMed ID: 17045167
[TBL] [Abstract][Full Text] [Related]
22. Lipid-Peptide-mRNA Nanoparticles Augment Radioiodine Uptake in Anaplastic Thyroid Cancer.
Li Q; Zhang L; Lang J; Tan Z; Feng Q; Zhu F; Liu G; Ying Z; Yu X; Feng H; Yi H; Wen Q; Jin T; Cheng K; Zhao X; Ge M
Adv Sci (Weinh); 2023 Jan; 10(3):e2204334. PubMed ID: 36453580
[TBL] [Abstract][Full Text] [Related]
23. The importance of sodium/iodide symporter (NIS) for thyroid cancer management.
Carvalho DP; Ferreira AC
Arq Bras Endocrinol Metabol; 2007 Jul; 51(5):672-82. PubMed ID: 17891230
[TBL] [Abstract][Full Text] [Related]
24. Novel therapy for anaplastic thyroid carcinoma cells using an oncolytic vaccinia virus carrying the human sodium iodide symporter.
Gholami S; Haddad D; Chen CH; Chen NG; Zhang Q; Zanzonico PB; Szalay AA; Fong Y
Surgery; 2011 Dec; 150(6):1040-7. PubMed ID: 22136819
[TBL] [Abstract][Full Text] [Related]
25. Role of Krüppel-Like Factor 4 in the Maintenance of Chemoresistance of Anaplastic Thyroid Cancer.
Lee SI; Kim DK; Seo EJ; Choi EJ; Kwon YW; Jang IH; Lee JC; Kim HY; Shong M; Kim JH; Kim SJ
Thyroid; 2017 Nov; 27(11):1424-1432. PubMed ID: 28920531
[TBL] [Abstract][Full Text] [Related]
26. Sodium/iodide symporter: a key transport system in thyroid cancer cell metabolism.
Filetti S; Bidart JM; Arturi F; Caillou B; Russo D; Schlumberger M
Eur J Endocrinol; 1999 Nov; 141(5):443-57. PubMed ID: 10576759
[TBL] [Abstract][Full Text] [Related]
27. Tunicamycin as a Novel Redifferentiation Agent in Radioiodine Therapy for Anaplastic Thyroid Cancer.
Choi YJ; Lee JE; Ji HD; Lee BR; Lee SB; Kim KS; Lee IK; Chin J; Cho SJ; Lee J; Lee SW; Ha JH; Jeon YH
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33499100
[TBL] [Abstract][Full Text] [Related]
28. Inhibiting β-catenin expression promotes efficiency of radioiodine treatment in aggressive follicular thyroid cancer cells probably through mediating NIS localization.
Lan L; Basourakos S; Cui D; Zuo X; Deng W; Huo L; Chen L; Zhang G; Deng L; Shi B; Luo Y
Oncol Rep; 2017 Jan; 37(1):426-434. PubMed ID: 27840971
[TBL] [Abstract][Full Text] [Related]
29. Rat sodium iodide symporter allows using lower dose of 131I for cancer therapy.
Mitrofanova E; Unfer R; Vahanian N; Link C
Gene Ther; 2006 Jul; 13(13):1052-6. PubMed ID: 16525480
[TBL] [Abstract][Full Text] [Related]
30. Targeting Novel Sodium Iodide Symporter Interactors ADP-Ribosylation Factor 4 and Valosin-Containing Protein Enhances Radioiodine Uptake.
Fletcher A; Read ML; Thornton CEM; Larner DP; Poole VL; Brookes K; Nieto HR; Alshahrani M; Thompson RJ; Lavery GG; Landa I; Fagin JA; Campbell MJ; Boelaert K; Turnell AS; Smith VE; McCabe CJ
Cancer Res; 2020 Jan; 80(1):102-115. PubMed ID: 31672844
[TBL] [Abstract][Full Text] [Related]
31. Radioiodine therapy of thyroid carcinoma following Pax-8 gene transfer.
Mu D; Huang R; Ma X; Li S; Kuang A
Gene Ther; 2012 Apr; 19(4):435-42. PubMed ID: 21833035
[TBL] [Abstract][Full Text] [Related]
32. Mesenchymal stem cell-mediated, tumor stroma-targeted radioiodine therapy of metastatic colon cancer using the sodium iodide symporter as theranostic gene.
Knoop K; Schwenk N; Schmohl K; Müller A; Zach C; Cyran C; Carlsen J; Böning G; Bartenstein P; Göke B; Wagner E; Nelson PJ; Spitzweg C
J Nucl Med; 2015 Apr; 56(4):600-6. PubMed ID: 25745085
[TBL] [Abstract][Full Text] [Related]
33. Selective sodium iodide symporter (
Spellerberg R; Benli-Hoppe T; Kitzberger C; Berger S; Schmohl KA; Schwenk N; Yen HY; Zach C; Schilling F; Weber WA; Kälin RE; Glass R; Nelson PJ; Wagner E; Spitzweg C
Mol Ther Oncolytics; 2021 Dec; 23():432-446. PubMed ID: 34853814
[TBL] [Abstract][Full Text] [Related]
34. Galectin-3 Targeting in Thyroid Orthotopic Tumors Opens New Ways to Characterize Thyroid Cancer.
De Rose F; Braeuer M; Braesch-Andersen S; Otto AM; Steiger K; Reder S; Mall S; Nekolla S; Schwaiger M; Weber WA; Bartolazzi A; D'Alessandria C
J Nucl Med; 2019 Jun; 60(6):770-776. PubMed ID: 30361380
[TBL] [Abstract][Full Text] [Related]
35. In vitro and in vivo properties of a human anaplastic thyroid carcinoma cell line transfected with the sodium iodide symporter gene.
Lee YJ; Chung JK; Shin JH; Kang JH; Jeong JM; Lee DS; Lee MC
Thyroid; 2004 Nov; 14(11):889-95. PubMed ID: 15671766
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of microRNA-875-5p promotes radioiodine uptake in poorly differentiated thyroid carcinoma cells by upregulating sodium-iodide symporter.
Tang Y; Meng X; Yu X; Shang H; Chen S; Liao L; Dong J
J Endocrinol Invest; 2020 Apr; 43(4):439-450. PubMed ID: 31612419
[TBL] [Abstract][Full Text] [Related]
37. A novel therapeutic strategy for medullary thyroid cancer based on radioiodine therapy following tissue-specific sodium iodide symporter gene expression.
Cengic N; Baker CH; Schütz M; Göke B; Morris JC; Spitzweg C
J Clin Endocrinol Metab; 2005 Aug; 90(8):4457-64. PubMed ID: 15941870
[TBL] [Abstract][Full Text] [Related]
38. Discovery of Potent, Selective, and Orally Bioavailable Estrogen-Related Receptor-γ Inverse Agonists To Restore the Sodium Iodide Symporter Function in Anaplastic Thyroid Cancer.
Kim J; Song J; Ji HD; Yoo EK; Lee JE; Lee SB; Oh JM; Lee S; Hwang JS; Yoon H; Kim DS; Lee SJ; Jeong M; Lee S; Kim KH; Choi HS; Lee SW; Park KG; Lee IK; Kim SH; Hwang H; Jeon YH; Chin J; Cho SJ
J Med Chem; 2019 Feb; 62(4):1837-1858. PubMed ID: 30657313
[TBL] [Abstract][Full Text] [Related]
39. In vivo molecular imaging and radionuclide (131I) therapy of human nasopharyngeal carcinoma cells transfected with a lentivirus expressing sodium iodide symporter.
Shi S; Zhang M; Guo R; Miao Y; Hu J; Xi Y; Li B
PLoS One; 2015; 10(1):e0116531. PubMed ID: 25621996
[TBL] [Abstract][Full Text] [Related]
40. An Inverse Agonist of Estrogen-Related Receptor Gamma, GSK5182, Enhances Na
Singh TD; Lee JE; Son KH; Lee BR; Kim SK; Gulwani D; Sarangthem V; Jeon YH
Cells; 2023 Feb; 12(3):. PubMed ID: 36766812
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
